Prospera Financial Services Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Prospera Financial Services Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.21 - $0.53 $210 - $530	-1,000 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.32 - $0.67 $320 - $670	1,000 New	1,000 $1,000
Q4 2020 Feb 12, 2021	SELL	$0.94 - $1.89 $2,350 - $4,725	-2,500 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$1.5 - $9.38 $3,750 - $23,450	2,500 New	2,500 $5,000
Q1 2020 May 15, 2020	SELL	$3.44 - $7.21 $78,432 - $164,388	-22,800 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$4.29 - $5.64 $15,015 - $19,740	-3,500 Reduced 13.31%	22,800 $124,000
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $173,580 - $205,140	26,300 New	26,300 $182,000
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $87,780 - $103,740	-13,300 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$5.76 - $8.95 $76,608 - $119,034	13,300 New	13,300 $97,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.